Jiangsu Recbio Technology Co., Ltd.
HKEX:2179.HK
7.96 (HKD) • At close July 2, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 319.04 | 834.983 | 1,325.15 | 1,182.562 | 355.821 | 57.239 |
| Short Term Investments
| 129.275 | 2.778 | 3.852 | 2.958 | 325.89 | 231.885 |
| Cash and Short Term Investments
| 448.315 | 837.761 | 1,325.15 | 1,182.562 | 681.711 | 289.124 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 62.299 | 118.076 | 56.16 | 23.549 | 7.762 | 7.363 |
| Other Current Assets
| 105.349 | 173.536 | 24.775 | 70.506 | 15.904 | 7.052 |
| Total Current Assets
| 655.129 | 1,129.373 | 1,419.92 | 1,294.571 | 709.376 | 310.65 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 1,089.415 | 884.233 | 813.837 | 511.372 | 256.213 | 84.47 |
| Goodwill
| 9.305 | 9.305 | 9.305 | 9.305 | 9.305 | 9.305 |
| Intangible Assets
| 37.432 | 41.126 | 33.505 | 22.12 | 22.12 | 22.12 |
| Goodwill and Intangible Assets
| 46.737 | 50.431 | 42.81 | 31.425 | 31.425 | 31.425 |
| Long Term Investments
| 0 | 2.4 | 31.404 | 80 | 50 | 0 |
| Tax Assets
| 0 | 0 | -31.404 | -80 | -50 | 0 |
| Other Non-Current Assets
| 148.951 | 119.84 | 33.04 | 81.852 | 50 | 0 |
| Total Non-Current Assets
| 1,285.103 | 1,056.904 | 889.687 | 624.649 | 337.638 | 115.895 |
| Total Assets
| 1,940.232 | 2,186.277 | 2,309.607 | 1,919.22 | 1,047.014 | 426.545 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 59.789 | 115.081 | 62.517 | 16.816 | 1.987 | 1.74 |
| Short Term Debt
| 510.217 | 61.038 | 21.755 | 7.862 | 4.334 | 3.131 |
| Tax Payables
| 0 | 0 | 0 | 0.687 | 2.173 | 0.932 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 269.414 | 268.116 | 244.711 | 113.928 | 48.987 | 11.995 |
| Total Current Liabilities
| 839.42 | 444.235 | 328.983 | 139.293 | 57.481 | 17.798 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 354.519 | 589.757 | 260.872 | 68.857 | 21.791 | 2.398 |
| Deferred Revenue Non-Current
| 0 | 75.811 | 61.144 | 32.244 | 18.122 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 5.53 | 5.53 | 5.53 | 5.53 | 5.53 |
| Other Non-Current Liabilities
| 216.969 | 0 | 0 | 0 | 1,952.874 | 725.896 |
| Total Non-Current Liabilities
| 571.488 | 671.098 | 327.546 | 106.631 | 1,998.317 | 728.294 |
| Total Liabilities
| 1,410.908 | 1,115.333 | 656.529 | 245.924 | 2,055.798 | 746.092 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 1,843.967 | 647.874 |
| Common Stock
| 482.963 | 482.963 | 482.963 | 448.25 | 36.069 | 29.356 |
| Retained Earnings
| 0 | -2,334.288 | -1,753.539 | -1,030.836 | -373.275 | -193.875 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 349.443 | 301.627 | -1,843.967 | -647.874 |
| Other Total Stockholders Equity
| 46.361 | 2,922.761 | 2,583.009 | 1,954.26 | 1,172.389 | 492.846 |
| Total Shareholders Equity
| 529.324 | 1,071.436 | 1,661.876 | 1,673.301 | -1,008.784 | -319.547 |
| Total Equity
| 529.324 | 1,070.944 | 1,653.078 | 1,673.296 | -1,008.784 | -319.547 |
| Total Liabilities & Shareholders Equity
| 1,940.232 | 2,186.277 | 2,309.607 | 1,919.22 | 1,047.014 | 426.545 |